JENNIFER STOLFER: Open Payments
NPI 1467964437 · LANCASTER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 38 payments from 14 companies in 2025. Trend: 2023 $469 · 2024 $662 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $185 |
| PFIZER INC. | 4 | $73 |
| Novo Nordisk Inc | 4 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $64 |
| Amgen Inc. | 3 | $47 |
| Lilly USA, LLC | 2 | $35 |
| Exact Sciences Corporation | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| KYOWA KIRIN, INC. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
Products named: QULIPTA, VRAYLAR, Kerendia, ELIQUIS, EVENITY, MOUNJARO, UBRELVY, Ozempic.
Industry payments across OH — which companies pay providers there.
